Dengue and chikungunya seroprevalence among Qatari nationals and immigrants residing in Qatar

John M. Humphrey, Enas S. Al-Absi, Munia M. Hamdan, Sara S. Okasha, Diyna M. Al-Trmanini, Hend G. El-Dous, Soha Dargham, John Schieffelin, Laith Aburaddad, Gheyath K. Nasrallah

Research output: Contribution to journalArticle

Abstract

The objective of this study is to characterize the seroprevalence of anti-dengue (DENV) and anti-chikungunya (CHIKV) antibodies among blood donors residing in Qatar who are Middle East and North Africa (MENA) nationals and non-nationals. Sera were collected from adult blood donors in Qatar from 2013 to 2016 and tested for anti-DENV and anti-CHIKV IgG using commercial microplate enzyme-linked immunosorbent assays. Age-specific seroprevalence was summarized by region/nationality: Asia (India, Philippines), Middle East (Iran, Jordan, Lebanon, Pakistan, Palestine, Syria, Yemen), North Africa (Egypt, Sudan), Qatar. The adjusted odds of anti-DENV and anti-CHIKV IgG seropositivity was estimated by logistic regression. Among 1,992 serum samples tested, Asian nationals had higher adjusted odds of being seropositive for anti-DENV antibodies compared to nationals of the Middle East (aOR 0.05, 95% CI 0.04–0.07), North Africa (aOR 0.14, 95% CI 0.10–0.20), and Qatar (aOR 0.01, 95% CI 0.01–0.03). Asian nationals also had higher adjusted odds of being seropositive for anti-CHIKV antibodies compared to those from the Middle East (aOR 0.14, 95% CI 0.07–0.27), North Africa (aOR 0.50, 95% CI 0.26–0.96), and Qatar (aOR 0.38, 95% CI 0.15–0.96). The adjusted odds of being anti-DENV seropositive was higher among anti-CHIKV seropositive adults, and vice versa (aOR 1.94, 95% CI 1.09–3.44), suggesting co-circulation of these viruses. DENV and CHIKV exposure is lower in Qatar and MENA nationals compared to Asian nationals suggesting a lower burden of DENV and CHIKV disease in the MENA. Antibodies to both viruses were detected in nationals from most MENA countries, supporting the need to better understand the regional epidemiology of these viruses.

Original languageEnglish
Article numbere0211574
JournalPLoS One
Volume14
Issue number1
DOIs
Publication statusPublished - 1 Jan 2019

Fingerprint

Qatar
Chikungunya virus
Northern Africa
Middle East
dengue
Dengue
Seroepidemiologic Studies
Viruses
immigration
seroprevalence
Eastern Africa
Antibodies
Blood
Epidemiology
Immunosorbents
antibodies
blood serum
Logistics
Blood Donors
Anti-Idiotypic Antibodies

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Humphrey, J. M., Al-Absi, E. S., Hamdan, M. M., Okasha, S. S., Al-Trmanini, D. M., El-Dous, H. G., ... Nasrallah, G. K. (2019). Dengue and chikungunya seroprevalence among Qatari nationals and immigrants residing in Qatar. PLoS One, 14(1), [e0211574]. https://doi.org/10.1371/journal.pone.0211574

Dengue and chikungunya seroprevalence among Qatari nationals and immigrants residing in Qatar. / Humphrey, John M.; Al-Absi, Enas S.; Hamdan, Munia M.; Okasha, Sara S.; Al-Trmanini, Diyna M.; El-Dous, Hend G.; Dargham, Soha; Schieffelin, John; Aburaddad, Laith; Nasrallah, Gheyath K.

In: PLoS One, Vol. 14, No. 1, e0211574, 01.01.2019.

Research output: Contribution to journalArticle

Humphrey, JM, Al-Absi, ES, Hamdan, MM, Okasha, SS, Al-Trmanini, DM, El-Dous, HG, Dargham, S, Schieffelin, J, Aburaddad, L & Nasrallah, GK 2019, 'Dengue and chikungunya seroprevalence among Qatari nationals and immigrants residing in Qatar', PLoS One, vol. 14, no. 1, e0211574. https://doi.org/10.1371/journal.pone.0211574
Humphrey JM, Al-Absi ES, Hamdan MM, Okasha SS, Al-Trmanini DM, El-Dous HG et al. Dengue and chikungunya seroprevalence among Qatari nationals and immigrants residing in Qatar. PLoS One. 2019 Jan 1;14(1). e0211574. https://doi.org/10.1371/journal.pone.0211574
Humphrey, John M. ; Al-Absi, Enas S. ; Hamdan, Munia M. ; Okasha, Sara S. ; Al-Trmanini, Diyna M. ; El-Dous, Hend G. ; Dargham, Soha ; Schieffelin, John ; Aburaddad, Laith ; Nasrallah, Gheyath K. / Dengue and chikungunya seroprevalence among Qatari nationals and immigrants residing in Qatar. In: PLoS One. 2019 ; Vol. 14, No. 1.
@article{4f939dcc4ba24725ab247c3db707c948,
title = "Dengue and chikungunya seroprevalence among Qatari nationals and immigrants residing in Qatar",
abstract = "The objective of this study is to characterize the seroprevalence of anti-dengue (DENV) and anti-chikungunya (CHIKV) antibodies among blood donors residing in Qatar who are Middle East and North Africa (MENA) nationals and non-nationals. Sera were collected from adult blood donors in Qatar from 2013 to 2016 and tested for anti-DENV and anti-CHIKV IgG using commercial microplate enzyme-linked immunosorbent assays. Age-specific seroprevalence was summarized by region/nationality: Asia (India, Philippines), Middle East (Iran, Jordan, Lebanon, Pakistan, Palestine, Syria, Yemen), North Africa (Egypt, Sudan), Qatar. The adjusted odds of anti-DENV and anti-CHIKV IgG seropositivity was estimated by logistic regression. Among 1,992 serum samples tested, Asian nationals had higher adjusted odds of being seropositive for anti-DENV antibodies compared to nationals of the Middle East (aOR 0.05, 95{\%} CI 0.04–0.07), North Africa (aOR 0.14, 95{\%} CI 0.10–0.20), and Qatar (aOR 0.01, 95{\%} CI 0.01–0.03). Asian nationals also had higher adjusted odds of being seropositive for anti-CHIKV antibodies compared to those from the Middle East (aOR 0.14, 95{\%} CI 0.07–0.27), North Africa (aOR 0.50, 95{\%} CI 0.26–0.96), and Qatar (aOR 0.38, 95{\%} CI 0.15–0.96). The adjusted odds of being anti-DENV seropositive was higher among anti-CHIKV seropositive adults, and vice versa (aOR 1.94, 95{\%} CI 1.09–3.44), suggesting co-circulation of these viruses. DENV and CHIKV exposure is lower in Qatar and MENA nationals compared to Asian nationals suggesting a lower burden of DENV and CHIKV disease in the MENA. Antibodies to both viruses were detected in nationals from most MENA countries, supporting the need to better understand the regional epidemiology of these viruses.",
author = "Humphrey, {John M.} and Al-Absi, {Enas S.} and Hamdan, {Munia M.} and Okasha, {Sara S.} and Al-Trmanini, {Diyna M.} and El-Dous, {Hend G.} and Soha Dargham and John Schieffelin and Laith Aburaddad and Nasrallah, {Gheyath K.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1371/journal.pone.0211574",
language = "English",
volume = "14",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "1",

}

TY - JOUR

T1 - Dengue and chikungunya seroprevalence among Qatari nationals and immigrants residing in Qatar

AU - Humphrey, John M.

AU - Al-Absi, Enas S.

AU - Hamdan, Munia M.

AU - Okasha, Sara S.

AU - Al-Trmanini, Diyna M.

AU - El-Dous, Hend G.

AU - Dargham, Soha

AU - Schieffelin, John

AU - Aburaddad, Laith

AU - Nasrallah, Gheyath K.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The objective of this study is to characterize the seroprevalence of anti-dengue (DENV) and anti-chikungunya (CHIKV) antibodies among blood donors residing in Qatar who are Middle East and North Africa (MENA) nationals and non-nationals. Sera were collected from adult blood donors in Qatar from 2013 to 2016 and tested for anti-DENV and anti-CHIKV IgG using commercial microplate enzyme-linked immunosorbent assays. Age-specific seroprevalence was summarized by region/nationality: Asia (India, Philippines), Middle East (Iran, Jordan, Lebanon, Pakistan, Palestine, Syria, Yemen), North Africa (Egypt, Sudan), Qatar. The adjusted odds of anti-DENV and anti-CHIKV IgG seropositivity was estimated by logistic regression. Among 1,992 serum samples tested, Asian nationals had higher adjusted odds of being seropositive for anti-DENV antibodies compared to nationals of the Middle East (aOR 0.05, 95% CI 0.04–0.07), North Africa (aOR 0.14, 95% CI 0.10–0.20), and Qatar (aOR 0.01, 95% CI 0.01–0.03). Asian nationals also had higher adjusted odds of being seropositive for anti-CHIKV antibodies compared to those from the Middle East (aOR 0.14, 95% CI 0.07–0.27), North Africa (aOR 0.50, 95% CI 0.26–0.96), and Qatar (aOR 0.38, 95% CI 0.15–0.96). The adjusted odds of being anti-DENV seropositive was higher among anti-CHIKV seropositive adults, and vice versa (aOR 1.94, 95% CI 1.09–3.44), suggesting co-circulation of these viruses. DENV and CHIKV exposure is lower in Qatar and MENA nationals compared to Asian nationals suggesting a lower burden of DENV and CHIKV disease in the MENA. Antibodies to both viruses were detected in nationals from most MENA countries, supporting the need to better understand the regional epidemiology of these viruses.

AB - The objective of this study is to characterize the seroprevalence of anti-dengue (DENV) and anti-chikungunya (CHIKV) antibodies among blood donors residing in Qatar who are Middle East and North Africa (MENA) nationals and non-nationals. Sera were collected from adult blood donors in Qatar from 2013 to 2016 and tested for anti-DENV and anti-CHIKV IgG using commercial microplate enzyme-linked immunosorbent assays. Age-specific seroprevalence was summarized by region/nationality: Asia (India, Philippines), Middle East (Iran, Jordan, Lebanon, Pakistan, Palestine, Syria, Yemen), North Africa (Egypt, Sudan), Qatar. The adjusted odds of anti-DENV and anti-CHIKV IgG seropositivity was estimated by logistic regression. Among 1,992 serum samples tested, Asian nationals had higher adjusted odds of being seropositive for anti-DENV antibodies compared to nationals of the Middle East (aOR 0.05, 95% CI 0.04–0.07), North Africa (aOR 0.14, 95% CI 0.10–0.20), and Qatar (aOR 0.01, 95% CI 0.01–0.03). Asian nationals also had higher adjusted odds of being seropositive for anti-CHIKV antibodies compared to those from the Middle East (aOR 0.14, 95% CI 0.07–0.27), North Africa (aOR 0.50, 95% CI 0.26–0.96), and Qatar (aOR 0.38, 95% CI 0.15–0.96). The adjusted odds of being anti-DENV seropositive was higher among anti-CHIKV seropositive adults, and vice versa (aOR 1.94, 95% CI 1.09–3.44), suggesting co-circulation of these viruses. DENV and CHIKV exposure is lower in Qatar and MENA nationals compared to Asian nationals suggesting a lower burden of DENV and CHIKV disease in the MENA. Antibodies to both viruses were detected in nationals from most MENA countries, supporting the need to better understand the regional epidemiology of these viruses.

UR - http://www.scopus.com/inward/record.url?scp=85060914060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060914060&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0211574

DO - 10.1371/journal.pone.0211574

M3 - Article

C2 - 30703150

AN - SCOPUS:85060914060

VL - 14

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 1

M1 - e0211574

ER -